Robbins LLP is Investigating the Allegations that Anavex Life Sciences Corporation (AVXL) Misled Investors Regarding the Likelihood of Success of its..
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) CEO Christopher U. Missling sold 73,380 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $5.11, for a total transaction of $374,971.80. Following the transaction, the chief executive officer now owns 1,250,210 shares in […]